Global Health Limited (MEDANTA) Share Price
NSE · Healthcare · Medical Care Facilities · ISIN INE474Q01031
Key metrics
- Market Cap
- ₹39,367 Cr
- P/E Ratio
- 71.08
- EPS
- 20.61
- Book Value
- 148.23
- P/B Ratio
- 9.88
- ROE
- 13.97%
- ROCE
- 14.05%
- Debt / Equity
- 0.3
- Net Margin
- 12.89%
- Revenue Growth
- 18.75%
- Profit Growth
- 15.58%
- Dividend Yield
- 0.03%
- 52W High
- ₹1,544.00
- 52W Low
- ₹956.00
- Market Cap Band
- large cap
- Face Value
- 2
Ratios computed from the annual results period ending 2026-03-31.
About Global Health Limited
Global Health Limited, together with its subsidiaries, provides healthcare services in India. The company offers treatments in the areas of digestive and hepatobiliary sciences, cardiac and cancer care, neurosciences, gastrosciences, orthopaedics, renal care, liver transplant, lung transplant, bone marrow transplant, chest surgery, gynaecology and gynaeoncology, paediatric care, obstetrics, emergency, ENT, head and neck surgery, internal medicine, respiratory and sleep medicine, peripheral vascular and endovascular sciences, endocrinology and diabetes, rheumatology and immunology, radiology and imaging, ophthalmology, critical care, dermatology, dentistry, lab and pathology, and dietetics and nutrition, as well as plastic, aesthetic, and reconstructive surgery. It also provides second opinions, lab tests and diagnostics, homecare and elder care services, telemedicine and air ambulance services, and e-ICU services, and health plans checkup services. In addition, the company is involved in trading pharmacy and other medical consumables; and medical and healthcare education activities. The company operates a network of hospitals under the Medanta brand. Global Health Limited was incorporated in 2004 and is based in Gurugram, India.
- Headquarters
- Gurugram, India
- Employees
- 12,600
- Promoter Holding
- 66.39%
The full Global Health Limited analysis
Create a free account to open the complete MEDANTA deep-dive — fourteen tabs of fundamental, technical, institutional and ownership data.
- 10-year financialsIncome statement, balance sheet and cash flow, year by year.
- Valuation & fair valueFair-value estimates, quality scores and a value grade.
- Charts & technicalsCandlestick charts, RSI, MACD, Supertrend and detected patterns.
- Shareholding historyPromoter, FII, DII and public holdings across every quarter.
- Ace investor holdingsWhich well-known investors hold it, and how their stake changed.
- Deals & insider tradesBulk and block deals, insider transactions and mutual-fund holdings.